Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

(2014) T. W. Ho et al.   NEUROLOGY

Classification of Perimenstrual Headache: Clinical Relevance

(2012) E. Anne MacGregor   Current Pain and Headache Reports

Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease

(2012) Tony W. Ho et al.   HEADACHE

Pure menstrual migraine with sensory aura: a case report

(2012) Jiann-Jy Chen et al.   JOURNAL OF HEADACHE AND PAIN

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

(2011) David J Hewitt et al.   CEPHALALGIA

Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: Application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan

(2010) David W Dodick et al.   CEPHALALGIA

Randomized, controlled trial of telcagepant over four migraine attacks

(2010) Andrew P Ho et al.   CEPHALALGIA

Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

(2010) Kathryn M. Connor et al.   HEADACHE

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology

Randomized, controlled trial of telcagepant for the acute treatment of migraine

(2009) K. M. Connor et al.   NEUROLOGY

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

(2008) Tony W Ho et al.   LANCET